Literature DB >> 1830583

Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase.

M J Berry1, J D Kieffer, J W Harney, P R Larsen.   

Abstract

The conversion of thyroxine to 3,5,3'-triiodothyronine (T3) is the first step in thyroid hormone action, and the Type I iodothyronine deiodinase supplies most of this extrathyroidal T3 in the rat. We found that the cDNA coding for this enzyme contains an in-frame UGA encoding the rare amino acid selenocysteine. Using site-directed mutagenesis, we have converted selenocysteine to cysteine and expressed the wild-type and cysteine mutant enzymes in JEG-3 cells by transient transfection. The kinetic properties of the transiently expressed wild-type enzyme are nearly identical to those reported for rat liver Type I deiodinase. Substitution of sulfur for selenium causes a 10-fold increase in the Km of the enzyme for the favored substrate 3,3',5'-triiodothyronine (rT3), a 100-fold decrease in the sensitivity of rT3 deiodination to competitive inhibition by gold and a 300-fold increase in the apparent Ki for uncompetitive inhibition by 6-n-propylthiouracil. These results demonstrate that selenium is responsible for the biochemical properties which characterize Type I iodothyronine monodeiodination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1830583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Two distinct SECIS structures capable of directing selenocysteine incorporation in eukaryotes.

Authors:  E Grundner-Culemann; G W Martin; J W Harney; M J Berry
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 2.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Diversity and functional plasticity of eukaryotic selenoproteins: identification and characterization of the SelJ family.

Authors:  Sergi Castellano; Alexey V Lobanov; Charles Chapple; Sergey V Novoselov; Mario Albrecht; Deame Hua; Alain Lescure; Thomas Lengauer; Alain Krol; Vadim N Gladyshev; Roderic Guigó
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

4.  Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cells.

Authors:  Filomena G Ottaviano; Shiow-Shih Tang; Diane E Handy; Joseph Loscalzo
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

5.  Combination of chemometrically assisted voltammetry, calorimetry, and circular dichroism as a new method for the study of bioinorganic substances: application to selenocystine metal complexes.

Authors:  Rui Gusmão; Rafel Prohens; José Manuel Díaz-Cruz; Cristina Ariño; Miquel Esteban
Journal:  J Biol Inorg Chem       Date:  2011-10-21       Impact factor: 3.358

Review 6.  Selenium metabolism and bioavailability.

Authors:  L A Daniels
Journal:  Biol Trace Elem Res       Date:  1996-09       Impact factor: 3.738

7.  Regulation of selenocysteine incorporation into the selenium transport protein, selenoprotein P.

Authors:  Sumangala P Shetty; Ravi Shah; Paul R Copeland
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

8.  Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme.

Authors:  D Salvatore; S C Low; M Berry; A L Maia; J W Harney; W Croteau; D L St Germain; P R Larsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

10.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.